| Name |
Posakonazol Zentiva 100 mg želučanootporne tablete |
| Former Name |
Posakonazol Alvogen 100 mg želučanootporne tablete |
| Marketing Authorisation Number |
HR-H-342674117 |
| Active Substance |
posakonazol |
| Composition |
svaka želučanootporna tableta sadrži 100 mg posakonazola |
| Pharmaceutical Form |
želučanootporna tableta |
| Manufacturer |
Delorbis Pharmaceuticals Ltd, Lefkosia, Ergates, Cipar |
| Marketing Authorisation Holder |
Zentiva k.s., U Kabelovny 130, Dolni Mecholupy, Prag 10, Češka |
| Marketing Authorisation Date |
04.01.2022 |
| MA Period of Validity |
unlimited |
| Classification Number |
UP/I-530-09/24-02/17 |
| Registration Number |
381-12-01/286-24-05 |
| Prescription |
Medicinal product subject to medical prescription |
| Type of prescription |
Medicinal product subject to restricted medical prescription
|
| Distribution |
Supply through pharmacies (community) |
| Advertising to general public |
not allowed |
| ATC Code |
J02AC04 |
| Marketing status |
Marketed |
| Shortage status |
No shortage |
| SmPC |
download |
| PL |
download |
| Public Assessment Report |
download
|
